欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/1176/002
药品名称
Lerimamed
活性成分
Hydrochlorothiazide 25.0 mg
Ramipril 5.0 mg
剂型
Tablet
上市许可持有人
Medochemie Ltd P.O. Box 51409 1-10 Constantinoupoleos Street 3011 Limassol Cyprus
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Lithuania (LT)
Ramimed HCT 5 mg/25 mg tabletės
Bulgaria (BG)
Ramimed HCT
Cyprus (CY)
RAMIMED HCT 5MG/25MG
Romania (RO)
Ramipril HCT - Medochemie 5 mg/25 mg
Slovakia (SK)
Ramimed HCT 5/25 tbl
许可日期
2007/10/05
最近更新日期
2025/01/28
药物ATC编码
C09BA05 ramipril and diuretics
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
1176 common_pil_v4_3_Jan_2022_clean
Date of last change:2024/09/06
Final SPC
|
1176 common_SmPC_v4_3_Jan_2022_clean
Date of last change:2024/09/06
Final Labelling
|
label_2_5_12_5_clean
Date of last change:2024/09/06
Final Labelling
|
label_5_25_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase